Dr. Beate Mueller-Tiemann

Chief Technology Officer

Dr. Beate Mueller-Tiemann’s career has reflected the entire pharma value chain from early target discovery, lead generation, lead optimization, cell line development, chemical manufacturing and control (CMC) production and commercial manufacturing for both Biologics and Synthetic Molecule therapeutics.

She applies her extensive experience in building R&D pipelines and her unapologetic optimism in science and technology to her leadership, as her teams create and bring high-quality products and innovative manufacturing and R&D processes closer to patients.

Beate joined Cytiva in early 2023, having held senior leadership positions at Sanofi and Bayer.

A former athlete who held the 800-meter record from at Fort-Le-Boeuf school district for decades, she believes in setting the pace and measuring performance. She finds inspiration in her diverse teams, when she sees the power of differing perspectives, experiences, opinions, and ideas being unleashed.

Beate earned her PhD at the Leibniz Institute of Virology in Hamburg, Germany in the field of Molecular Oncology. She holds master’s degrees in biology and Biochemistry from the University of Bielefeld, Germany, and the University of Montpellier in France.

Beate is an elected member of the Board of the Dechema, German Society for Chemical Engineering and Biotechnology. She supports female talents with mentoring programs and is a member of FiDAR, an association that works towards increasing the representation of women on German corporate boards.

She is based in Frankfurt, Germany.